TOMSICEK MICHAEL JOHN
SEC CIK 1570392 · EDGAR
BoughtSold
Most active insiders at ACRV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Blume-Jensen Peter | Pres, CEO, Dir | $82.3K | $34.4K |
| 2 | Devroe Eric | COO | $17.2K | $1,214 |
| 3 | Levy Adam D. | CFO | $15.0K | $1,793 |
| 4 | Miller Mary | CLO | — | $1,380 |
| 5 | Gamelin Erick | Chief Development Off | — | $804.00 |
| 6 | Peterson Katharine | CAO | — | $203.01 |
| 7 | Levin Michaela | Chief Business Off | — | — |
| 8 | Palani Santhosh | Dir | — | — |
| 9 | Masson Kristina | EVP - Business Ops, Dir | — | — |
| 10 | DiRocco Derek | Dir | — | — |
| 14 | TOMSICEK MICHAEL JOHN | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-20 16:36 | 2026-05-18 | ACRV | Acrivon Therapeutics, Inc. | TOMSICEK MICHAEL JOHN | Dir | A - Grant | $0.00 | +9,366 | 9,366 | New | $0 | |
| 2022-10-21 | 2022-10-19 | MIST | Milestone Pharmaceuticals Inc. | TOMSICEK MICHAEL JOHN | Dir | P - Purchase | $5.32 | +15.0K | 15.0K | New | +$79.8K | |
| D | 2021-08-10 | 2021-08-06 | CRSP | CRISPR Therapeutics AG | TOMSICEK MICHAEL JOHN | CFO | M - OptEx | $17.75 | +25.0K | 26.9K | +1,322% | +$443.8K |
| DM | 2021-08-10 | 2021-08-06 | CRSP | CRISPR Therapeutics AG | TOMSICEK MICHAEL JOHN | CFO | S - Sale+OE | $138.52 | -25.0K | 1,891 | -93% | -$3.46M |
Purchase Sale Sale after option exercise All abbreviations